About US
Ostodis and Axiadis SAM are Monegasque Limited companies, with registered office at 15/15, Bis Bd Princesse Charlotte.
We are one of the leading distributors of medical devices in the field of orthopaedics.
The products offered to our clients originate from French manufacturers and faithful partners : hip prosthesis, knees, ligamentoplasty, bone substitutes, osteosynthesis, foot, shoulder & spine surgery … (non-exhaustive list).
Our network of sales agents and IDE/IBODE are attentive to our customers’ needs in order to best satisfy their requests so that the patient’s welfare remains our priority.
We are ISO 13485 certified by AFAQ-AFNOR Certification since 2006
Our team :
The Management and Administrative Departments are monitored by our Head Office in Monaco by the following services :
- Management
- Quality / Regulatory Affairs
- Sales (ADV)
- Private and public Tenders / Events
- Logistics
- Accounting
Certifications ISO et compliance
Products
Products dedicated to health professionals
OSTODIS / AXIADIS exclusive distributors in France
Documentation
Notice
European Journal of Orthopaedic Surgery & Traumatology - 01 July 2023
European Spine Journal - 19 January 2023
| REFERENCES | SIZE | UNITS |
|---|---|---|
| PAT35X6 | 3,5 x 6 x 0,6 cm | 1 unit per box |
| PAT7X11 | 7 x 11 x 0,6 cm | 1 unit per box |
| PAT1X1X1 | 1 x 1 x 1 cm | 5 units per box |
COLLAPAT®II BENEFITS
- Osteoconductive
- Haemostatic effect
- Ready to use and easy to handle, to mold and to trim1 1
- Hydrophilic
- Perfect fitting
The SYMATESE Collagen Technology Platform gives to COLLAPAT®II its specifications
► The complete process is integrated to ensure SAFETY, QUALITY and RELIABILITY.
► Cellular affinities, preservation of collagen’s biochemical and biological qualities for tissue reconstruction.
► Extensive, proprietary extraction and purification process make COLLAPAT®II perfectly biocompatible.
► The porous COLLAPAT®II three dimensional mineral structure enhance osteoblast differentiation and accelerate osteogenesis in the entire graft site. Customized cross-linking process allows maintaining the collagen structure while the patient’s cells colonize the graft, and allows for the collagen resorption after bone replacement2.
1- SYMATESE internal data – NOT 138.
2- SYMATESE internal data – COLLAPAT®II Clinical Evaluation Report.
Partners
We do have a faithful partnership.
C2F IMPLANTS
DEDIENNE SANTE
EVOLUTIS
SYMATESE
COUSIN SURGERY
FH ORTHO
EXACTECH
EUROS
STRYKER
SERF
UNITED ORTRHOPEDIC
CONTACT
OSTODIS SAM - Villa les Lauriers – 15/15, Bis Boulevard Princesse Charlotte – 98000 MONACO
info@ostodis.com
Vert : 0800.917.157 - N° Fax Vert : 0800.905.452
Rachel MORENO
General Manager
Tél. : +377.97.97.61.35
Fax : +377.93.50.93.01
Yvette GUERRA
Sales Manager
Tél : +377.93.50.85.57
Fax : +377.93.50.93.01
y.guerra@ostodis.com
Alain FORLAI
Accountings department
Tél : +377.97.97.61.33
Fax : +377.93.50.93.01
a.forlai@ostodis.com
Public Tenders / Events
Tél : +377.93.50.93.00
Fax : +377.93.50.93.01
marches@ostodis.com
Quality / Regulatory Affairs
Tél : +377.93.50.93.00
Fax : +377.93.50.93.01
qualite@ostodis.com